Philogen

Philogen Announces EUR62 Million Financing Round

Philogen S.p.A (or the "Company"), a clinical-stage biotechnology company focused on antibody-based therapeutics, today is pleased to announce a EUR62 million financing round from current and new private …

OTE0006
13.05.2019 09:01